Predict your next investment

Private Equity
stonecreekcapital.com

See what CB Insights has to offer

Investments

1

Funds

1

About StoneCreek Capital

Founded in 1992, StoneCreek Capital is a Irvine, California based private equity firm.

StoneCreek Capital Headquarter Location

18500 Von Karman Ave Suite 590

Irvine, California, 92612,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest StoneCreek Capital News

Abacus Finance Group Backs Kova Deal

Feb 25, 2013

Abacus Finance Group Backs Kova Deal February 25, 2013 Follow @buyouts Abacus Finance Group was administrative agent and sole lead arranger for $16.5 million in debt financing used to support the spinout of Kova International from Hycor Biomedical. Garden Grove, Calif.-based Kova is a developer, manufacturer, and marketer of in-vitro diagnostic products for the urinalysis market. PRESS RELEASE Abacus Finance Group, LLC (Abacus), a New York-based specialty finance company, announced today that it served as Administrative Agent and Sole Lead Arranger for $16.5 million in senior secured credit facilities to support the divisional spin out of Kova International (Kova) from Hycor Biomedical, Inc. by an investor group consisting of One Rock Capital Partners, LLC (One Rock), Laurel Crown Partners, StoneCreek Capital and management. Abacus focuses exclusively on providing cash-flow financing for private equity-sponsored, lower-middle market companies. Based in Garden Grove, CA, Kova is the leading developer, manufacturer, and marketer of in-vitro diagnostic products for the global urinalysis market. One Rock, based in New York City, is a private investment company that provides equity capital for high-potential small and middle-market businesses. “We chose to partner with Abacus for this investment because of their expertise in financing healthcare companies and their ability to assure a certainty of close early on,” said One Rock Partner Kimberly D. Reed. “Abacus was highly recommended to us. They were easy to work with and flexible in structuring the transaction, which gives us the foundation to pursue our growth strategy.” “One Rock, a new relationship for us, is a great fit for our firm given their investment strategy and their sector focus,” said Tim Clifford, President and CEO of Abacus. “They were terrific to work with, and we were impressed by the thoroughness of their due diligence. As in other transactions, the critical success factors came down to our flexibility and our ability to provide certainty of close – both important aspects of what we call our Total Partnership ApproachTM.” Other Abacus team members involved in the transaction included Mindy Naylor and Song Pettus. Goulston & Storrs, LLP provided legal counsel to Abacus. About Kova International Founded in 1981 and based in Garden Grove, CA, Kova is the leading developer, manufacturer, and marketer of in-vitro diagnostic products for the global urinalysis market. Kova is recognized as a premier brand in urinalysis with exceptional product recognition among clinicians and lab technicians. Its products are entrenched in all segments of urinalysis testing, and for over 20 years Kova has maintained a leading market position in disposable microscopy urinalysis products. For more information, visit kova.com. About One Rock Capital Partners, LLC One Rock Capital Partners is a private investment company that provides equity capital for high-potential middle-market businesses. One Rock enhances the value of its portfolio companies by bringing world-class operational, strategic, and financial resources to help company management achieve its goals. Its resources include a group of hands-on, highly accomplished, industry-specific Operating Partners and a strategic partnership with Mitsubishi Corporation. For more information, visit onerockcapital.com. About Abacus Finance Group, LLC Abacus Finance, headquartered in New York, is a lower-middle market specialty finance company, focused on providing senior cash-flow financing to private equity-sponsored companies nationwide. Formed in June 2011, Abacus targets debt financing opportunities of up to $50 million with a typical hold size ranging from $10 million to $25 million, and the companies it finances generally have EBITDA between $3 million and $15 million. Abacus is an affiliate of New York Private Bank & Trust, the holding company for Emigrant Bank, which was founded in 1850 and is the largest family-owned bank in America. Abacus is headquartered at 6 East 43rd Street, 20th Floor, New York, NY 10017. All inquiries and new investment opportunities should be directed to Tim Clifford at 212-850-4620 or to [email protected] Visit abacusfinance.com for more information. © 2015 Buyouts Insider / Argosy Group LLC

StoneCreek Capital Investments

1 Investments

StoneCreek Capital has made 1 investments. Their latest investment was in Hycor Biomedical's Urinalysis Business as part of their Private Equity on February 2, 2013.

CBI Logo

StoneCreek Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/20/2013

Private Equity

Hycor Biomedical's Urinalysis Business

Yes

1

Date

2/20/2013

Round

Private Equity

Company

Hycor Biomedical's Urinalysis Business

Amount

New?

Yes

Co-Investors

Sources

1

StoneCreek Capital Acquisitions

3 Acquisitions

StoneCreek Capital acquired 3 companies. Their latest acquisition was ACCESS Destination Services on March 19, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/19/2018

$99M

Acq - Fin

1

2/19/2013

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

10/1/2011

Subscribe to see more

$99M

Subscribe to see more

0

Date

3/19/2018

2/19/2013

10/1/2011

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$99M

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

1

10

0

StoneCreek Capital Fund History

1 Fund History

StoneCreek Capital has 1 fund, including Gordon Morris Investment Partnership, L.P..

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/1995

Gordon Morris Investment Partnership, L.P.

Buyouts & Acquisitions

Closed

$61M

1

Closing Date

12/31/1995

Fund

Gordon Morris Investment Partnership, L.P.

Fund Type

Buyouts & Acquisitions

Status

Closed

Amount

$61M

Sources

1

StoneCreek Capital Team

2 Team Members

StoneCreek Capital has 2 team members, including current President, Drew H. Adams.

Name

Work History

Title

Status

Bruce N. Lipian

Founder

Current

Drew H. Adams

President

Current

Name

Bruce N. Lipian

Drew H. Adams

Work History

Title

Founder

President

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.